{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:13:27Z","timestamp":1792257207773,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020295","name":"Natera Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013896","name":"BioGaia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajog.2023.03.026","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T17:49:50Z","timestamp":1679593790000},"page":"300.e1-300.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-1701","authenticated-orcid":false,"given":"Mary E.","family":"Norton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Demko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Egbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeevi","family":"Madankumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Haeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Hyett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pe\u2019er","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.03.026_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2023.03.026_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.03.026_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/uog.13418","article-title":"Repeated failed non-invasive prenatal testing owing to low cell-free fetal DNA fraction and increased variance in a woman with severe autoimmune disease","volume":"44","author":"Hui","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib5","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"35","author":"Taglauer","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2023.03.026_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2019.04.002","article-title":"Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy","volume":"16","author":"Gerson","year":"2019","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2023.03.026_bib7","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00439-019-02058-w","article-title":"The significance of the placental genome and methylome in fetal and maternal health","volume":"139","author":"Del Gobbo","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.ajog.2023.03.026_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/uog.1923","article-title":"Placental volume measured by three-dimensional ultrasound at 11 to 13\u00a0+ 6 weeks of gestation: relation to chromosomal defects","volume":"26","author":"Wegrzyn","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1933719115584445","article-title":"Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma","volume":"22","author":"Zhou","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2023.03.026_bib10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/gim.2018.22","article-title":"Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing","volume":"20","author":"Palomaki","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2023.03.026_bib11","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2022.01.002","article-title":"Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome","volume":"227","author":"Dar","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib12","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2022.01.019","article-title":"Cell-free DNA screening for trisomies 21, 18, and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation","volume":"227","author":"Dar","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/AOG.0000000000002728","article-title":"Factors associated with informative redraw after an initial no result in noninvasive prenatal testing","volume":"132","author":"Benn","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib14","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A\u00a0United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.4613","article-title":"Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2023.03.026_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2215-0366(18)30168-8","article-title":"Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study","volume":"5","author":"Olsen","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ajog.2023.03.026_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/AOG.0000000000002752","article-title":"Influence of body mass index on fetal fraction increase with gestation and cell-free DNA test failure","volume":"132","author":"Rolnik","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tjog.2019.11.003","article-title":"Causes of aberrant non-invasive prenatal testing for aneuploidy: a systematic review","volume":"59","author":"Samura","year":"2020","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14737159.2022.2049245","article-title":"Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study","volume":"22","author":"Lu","year":"2022","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ajog.2023.03.026_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clinbiochem.2021.07.004","article-title":"More attention should be paid to pregnant women who fail non-invasive prenatal screening","volume":"96","author":"Zhang","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ajog.2023.03.026_bib23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/pd.6034","article-title":"Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: analysis of a subcohort of the TRIDENT-2 study","volume":"41","author":"Becking","year":"2021","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2023.03.026_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia","volume":"52","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0038-1667374","article-title":"Association of fetal fraction of cell-free DNA and hypertensive disorders of pregnancy","volume":"36","author":"Bender","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.03.026_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000346806","article-title":"Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2023.03.026_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.placenta.2012.11.001","article-title":"Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications","volume":"34","author":"Kim","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2023.03.026_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/pd.1645","article-title":"Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia","volume":"27","author":"Crowley","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2023.03.026_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/pd.4093","article-title":"RASSF1A in maternal plasma as a molecular marker of preeclampsia","volume":"33","author":"Papantoniou","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2023.03.026_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/pd.2372","article-title":"Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction","volume":"29","author":"Illanes","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2023.03.026_bib31","doi-asserted-by":"crossref","first-page":"472.e1","DOI":"10.1016\/j.ajog.2009.05.025","article-title":"First-trimester maternal plasma cell-free fetal DNA and preeclampsia","volume":"201","author":"Sifakis","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jhg.2016.25","article-title":"Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy","volume":"61","author":"Suzumori","year":"2016","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.ajog.2023.03.026_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.15851","article-title":"Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result","volume":"47","author":"Revello","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.03.026_bib34","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.ajog.2023.03.026_bib35","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities: ACOG Practice Bulletin, Number 226","volume":"136","year":"2020","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:37:43Z","timestamp":1762079863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0002937823001722"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.03.026","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}